Search results for: 'platform screen dots'

This research services provides an overview of the global CAD in breast cancer screening market and a 5-year forecast from 2021 to 2026. The market will grow from $118.0 million in 2021 to $165.7 million in 2026, increasing at a compound annual growth rate (CAGR) of 7.0%. The mammo-CAD and ultrasound-CAD segments will grow at the highest rates due ...

This research service analyzes the market for high content screening technologies within the United States. The market was divided into the high content screening instrumentation and high content screening reagents and assays segments. Each segment covers market trends, technology trends, competitive structure, market share analysis, revenue foreca...

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

The pandemic years left different learnings in terms of mental and behavioral health. The isolation addressed the migration of patients with different needs and conditions from on-site treatments to digital platforms and solutions, highlighting benefits and challenges for providers and users. The main pivotal change is a new, holistic mental and be...

This report provides a strategic analysis and forecast of the HTS market. The major segments included in the scope of this report are consumables, contract screeners, and biotechnology& pharmaceuticals. Each segment covers technology, products, deals, patents, industry trends, and a revenue forecast and analysis. General market challenges, driver...

17 Jul 2017  |  North America  |  Market Research

US Oncology Diagnostics Market, Forecast to 2021

Manufacturers Increase Assay Development Focus Toward Screening, Prevention, and Therapy Selection

Infographics

×

Personalized medicine continues to be a driver of new diagnostics to characterize the properties of an individual’s cancer. As a result, there is an increased focus on the development of non-invasive liquid biopsy companion diagnostic tests that would aid in choosing the best treatment for an individual. Liquid biopsy has triggered market consolida...

Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...

28 Feb 2022  |  North America  |  Market Research

Growth Opportunities for Platform Approaches in Healthcare, Global

Digital Technologies, User Experience, and Clinical Expertise Will Drive Transformational Growth

Infographics

×

Despite being one of the largest and fastest-growing industries, healthcare is too often slow to innovate. Healthcare services and data are both extremely fragmented, often work in silos, create process inefficiencies, and constrain access and affordability. Digital platforms offer integration and interoperability between applications and solut...

During the last decade, adoption of robot-assisted surgery has increased significantly as opportunities have multiplied for performing minimally invasive procedures. Overall, surgical robotic platforms facilitate more precise surgeries and improve the repeatability of procedural movements. These benefits support faster recovery and better outcomes ...